BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12918941)

  • 1. Immunoadsorption in systemic lupus erythematosus: different techniques and their current role in medical therapy.
    Gaubitz M; Schneider KM
    Ther Apher Dial; 2003 Apr; 7(2):183-8. PubMed ID: 12918941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy.
    Schneider KM
    Kidney Int Suppl; 1998 Feb; 64():S61-5. PubMed ID: 9475492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma- and lymphapheresis in autoimmune diseases].
    Schneider M
    Z Rheumatol; 1996; 55(2):90-104. PubMed ID: 8686387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoadsorption in Autoimmune Diseases Affecting the Kidney.
    Stummvoll G; Aringer M; Handisurya A; Derfler K
    Semin Nephrol; 2017 Sep; 37(5):478-487. PubMed ID: 28863794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus.
    Braun N; Erley C; Klein R; Kötter I; Saal J; Risler T
    Nephrol Dial Transplant; 2000 Sep; 15(9):1367-72. PubMed ID: 10978392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadsorption in systemic connective tissue diseases and primary vasculitis.
    Schneider M; Gaubitz M; Perniok A
    Ther Apher; 1997 May; 1(2):117-20. PubMed ID: 10225754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption (IAS) for systemic lupus erythematosus.
    Stummvoll GH
    Lupus; 2011 Feb; 20(2):115-9. PubMed ID: 21303827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus.
    Schneider M; Berning T; Waldendorf M; Glaser J; Gerlach U
    J Rheumatol; 1990 Jul; 17(7):900-7. PubMed ID: 2213756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review.
    Kronbichler A; Brezina B; Quintana LF; Jayne DR
    Autoimmun Rev; 2016 Jan; 15(1):38-49. PubMed ID: 26318215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoadsorption for systemic lupus erythematosus.
    Stummvoll GH; Julius U; Derfler K; Aringer M
    Atheroscler Suppl; 2009 Dec; 10(5):110-3. PubMed ID: 20129387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus erythematosus: a feasibility evaluation study.
    Hershko AY; Scheiman-Elazari A; Aamar S; Naparstek Y
    Immunol Res; 2013 Jul; 56(2-3):376-81. PubMed ID: 23584986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
    Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
    Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.
    Gaubitz M; Seidel M; Kummer S; Schotte H; Perniok A; Domschke W; Schneider M
    J Autoimmun; 1998 Oct; 11(5):495-501. PubMed ID: 9802935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful pregnancy and delivery in a case of systemic lupus erythematosus treated with immunoadsorption therapy and cyclosporin A.
    Maeshima E; Yamada Y; Kodama N; Mune M; Yukawa S
    Scand J Rheumatol; 1999; 28(1):54-7. PubMed ID: 10092166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid reduction of antibodies and improvement of disease activity by immunoadsorption in Chinese patients with severe systemic lupus erythematosus.
    Huang J; Song G; Yin Z; He W; Zhang L; Kong W; Ye Z
    Clin Rheumatol; 2016 Sep; 35(9):2211-8. PubMed ID: 27488202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadsorption therapy (therasorb) in patients with severe lupus erythematosus.
    Graninger M; Schmaldienst S; Derfler K; Graninger WB
    Acta Med Austriaca; 2002; 29(1):26-9. PubMed ID: 11899750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis-immunoadsorption for treatment of systemic lupus erythematosus in a dog.
    Matus RE; Scott RC; Saal S; Gordon BR; Hurvitz AI
    J Am Vet Med Assoc; 1983 Mar; 182(5):499-502. PubMed ID: 6339455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis.
    Esnault VL; Testa A; Jayne DR; Soulillou JP; Guenel J
    Nephron; 1993; 65(2):180-4. PubMed ID: 8247177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of systemic lupus erythematosus by extracorporeal immunoadsorption.
    Palmer A; Gjorstrup P; Severn A; Welsh K; Taube D
    Lancet; 1988 Jul; 2(8605):272. PubMed ID: 2899250
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of DNA Immunoadsorption Combined with Medication on Immune Function and Renal Function in Patients with Systemic Lupus Erythematosus.
    Bai L; Sun M; Wu G; Wang J; Wang Y; Shi J; Zhang L
    J Environ Public Health; 2023; 2023():2843979. PubMed ID: 36864896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.